Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 12, 2007

New Mexico Tech to Assist Biomoda with Lung Cancer Detection Test

  • Biomoda and New Mexico Institute of Mining and Technology are partnering to develop a diagnostic product for lung cancer. The collaborators will work together on clinical studies to develop a specialized image-recognition technology.

    This is a part of the company's commercialization of its assay for the early detection of lung cancer. Biomoda's technology, a noninvasive cytology-based assay, is designed for cancer screening of large populations at a reasonable cost.

    Current diagnostic methods for lung cancer, including CT scans and X-rays, often detect the disease only at more advanced stages and are relatively expensive, according to the company.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »